Our bodies are home to millions of fungi that, for the most part, are completely harmless. However, they can sometimes change ...

Orsini, a leader in rare disease pharmacy solutions, has been selected by Genetix Biotherapeutics Inc. as a specialty pharmacy partner for three FDA-approved autologous hematopoietic stem cell-based ...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced financial results for ...

These are some of the most common issues that a sore throat could be the first indicator of a more pressing issue.

These are some of the most common issues that a sore throat could be the first indicator of a more pressing issue.

As we age, our immune systems can naturally weaken, allowing viruses that have been "sleeping" in our bodies for decades to ...

New research suggests that Epstein-Barr virus may actively provoke the immune system in people with multiple sclerosis. Scientists found large buildups of virus-targeting immune cells in the nervous ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...

Some types of CD8+ T cells (killer T cells) may play a role in the development of multiple sclerosis (MS). This is according to data from a new study published in Nature Immunology. Specifically, ...

Infections with Epstein–Barr virus (EBV) are very common; the virus is estimated to have infected at least 90% of all adults worldwide. It can easily be transmitted through the saliva of an infected ...

Nine in 10 people worldwide have been infected with Epstein-Barr virus (EBV). But only a small number will go on to develop serious illnesses that have been linked to the virus, such as lupus, chronic ...

ROCHESTER, N.Y. (WROC) – With what has already been a severe flu season, local doctors are starting to see an uptick in another illness: Norovirus. “I will say in the last week or so, we have seen an ...